Effective dose of intranasal dexmedetomidine for struggle free induction of anaesthesia in children with retinoblastoma undergoing examination under anaesthesia
Not Applicable
- Conditions
- Health Condition 1: C692- Malignant neoplasm of retina
- Registration Number
- CTRI/2021/02/031258
- Lead Sponsor
- arayana Nethralaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
40 ASA I-III children with known or suspected retinoblastoma aged 1-60 months undergoing EUA ± focal therapy
Exclusion Criteria
The exclusion criteria are lack of parental consent, known allergy to dexmedtomidine, nasal discharge, renal or hepatic dysfunction, any serious systemic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method